International Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi.


Journal

Archives of physical medicine and rehabilitation
ISSN: 1532-821X
Titre abrégé: Arch Phys Med Rehabil
Pays: United States
ID NLM: 2985158R

Informations de publication

Date de publication:
03 2023
Historique:
received: 01 03 2022
revised: 27 06 2022
accepted: 30 07 2022
pubmed: 29 8 2022
medline: 8 3 2023
entrez: 28 8 2022
Statut: ppublish

Résumé

To establish international recommendations for the management of spastic equinovarus foot deformity. Delphi method. International study. A total of 24 international experts (N=24) in neuro-orthopedic deformities, from different specialties (Physical and Rehabilitation Medicine physicians, neurologists, geriatricians, orthopedic surgeons, neurosurgeons, plastic surgeons). Experts answered 3 rounds of questions related to important aspects of diagnosis, assessment, and treatment of spastic equinovarus foot deformity. A consensus was established when at least 80% of experts agreed on a statement RESULTS: A total of 52 items reached consensus. Experts recommend assessing effect of the deformity on functional activities before treatment. Before treatment, it is crucial to differentiate spastic muscle overactivity from soft tissue contractures, identify which muscles are involved in the deformity, and evaluate the activity of antagonist muscles. Motor nerve blocks, 2-dimensional video analysis, and radiologic examinations are often required to complement a clinical examination. The treatment of equinovarus foot depends on the correctability of the deformity and the patient's ability to stand or walk. The preoperative assessment should include an interdisciplinary consultation that must finalize a formal agreement between physicians and the patient, which will define personalized attainable goals before surgery. The establishment of guidelines on managing equinovarus foot will help physicians and surgeons, specialists, and nonspecialists to diagnoses and assess the deformity and direct patients to a network of experts to optimize patient functional recovery and improve their autonomy.

Identifiants

pubmed: 36030892
pii: S0003-9993(22)00595-0
doi: 10.1016/j.apmr.2022.07.020
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

372-379

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Marjorie Salga (M)

UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France; Versailles Saint-Quentin-en-Yvelines University (UVSQ), UFR Simone Veil - Santé, Montigny-le-Bretonneux, France; Garches Neuro-Orthopaedics Research Group (GRENOG), Garches, France.

Laure Gatin (L)

UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France; Versailles Saint-Quentin-en-Yvelines University (UVSQ), UFR Simone Veil - Santé, Montigny-le-Bretonneux, France; Garches Neuro-Orthopaedics Research Group (GRENOG), Garches, France; Department of Orthopaedic Surgery, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France.

Thierry Deltombe (T)

Department of Physical Medicine and Rehabilitation, CHU UCL Namur site Godinne, Yvoir, Belgium; Canadian Advances in Neuro-Orthopedics for Spasticity Congress (CANOSC), Kingston, Ontario, Canada.

Thierry Gustin (T)

Department of Neurosurgery, CHU UCL Namur site Godinne, Yvoir, Belgium.

Stefano Carda (S)

Service of Neuropsychology and Neurorehabilitation, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Philippe Marque (P)

ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France; Department of Neurological Rehabilitation, University Hospital of Toulouse, Hôpital de Rangueil, Toulouse, France.

Paul Winston (P)

Canadian Advances in Neuro-Orthopedics for Spasticity Congress (CANOSC), Kingston, Ontario, Canada; Division of Physical Medicine and Rehabilitation, University of British Columbia, Victoria, British Columbia, Canada.

Rajiv Reebye (R)

Division of Physical Medicine and Rehabilitation, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Theodore Wein (T)

Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Alberto Esquenazi (A)

MossRehab and Albert Einstein Medical Center, Elkins Park, Pennsylvania.

Mary-Ann Keenan (MA)

Penn Neuro-Orthopaedics Service, University of Pennsylvania, Philadelphia, Pennsylvania.

Franco Molteni (F)

Villa Beretta Rehabilitation Center, Valduce Hospital, Costa Masnaga, Italy.

Paolo Zerbinati (P)

Gait and Motion Analysis Laboratory, Sol et Salus Hospital, Rimini, Italy; U.O. Neuroortopedia, Ospedale Santa Maria Multimedica Castellanza, Varese, Italy.

Alessandro Picelli (A)

Section of Physical and Rehabilitation Medicine, Department of Neurosciences, Biomedicine and Movement Sciences, Neuromotor and Cognitive Rehabilitation Research Center, University of Verona, Verona, Italy.

Flavia Coroian (F)

Physical and Rehabilitation Medicine Department, Montpellier University Hospital, Montpellier, France; Euromov, Montpellier University, Montpellier, France.

Bertrand Coulet (B)

Hand and Upper Limb Surgery Department, CHRU Lapeyronie, Montpellier, France.

Nadine Sturbois-Nachef (N)

Canadian Advances in Neuro-Orthopedics for Spasticity Congress (CANOSC), Kingston, Ontario, Canada; Department of Orthopedic Surgery, Lille University Medical Center, Lille, France.

Christian Fontaine (C)

Department of Orthopedic Surgery, Lille University Medical Center, Lille, France.

Alain Yelnik (A)

Department of Physical and Rehabilitation Medicine, Université de Paris, AP-HP Hospital Fernand Widal, Paris, France.

Bernard Parratte (B)

Department of Physical and Rehabilitation Medicine, CHRU Jean Minjoz, Besançon-Franche-Comté University, Besançon, France.

Prakash Henry (P)

Department of Neurological Rehabilitation, Christian Medical College, Vellore, India.

Srikant Venkatakrishnan (S)

Department of Neurological Rehabilitation, NIMHANS, Bangalore, India.

Philippe Rigoard (P)

Institut Pprime CNRS - Université de Poitiers - ISAE-ENSMA, Poitiers, France; Spine and Neuromodulation Functional Unit, Department of Neurosurgery, CHU Poitiers, PRISMATICS Lab, Poitiers, France.

Romain David (R)

Department of Physical and Rehabilitation Medicine, University Hospital Center of Poitiers, PRISMATICS Lab, Poitiers, France.

Philippe Denormandie (P)

UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France; Department of Orthopaedic Surgery, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France.

Alexis Schnitzler (A)

Department of Physical and Rehabilitation Medicine, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France.

Etienne Allart (E)

Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, Neurorehabilitation Unit, Lille, France.

François Genet (F)

UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France; Versailles Saint-Quentin-en-Yvelines University (UVSQ), UFR Simone Veil - Santé, Montigny-le-Bretonneux, France; Garches Neuro-Orthopaedics Research Group (GRENOG), Garches, France. Electronic address: francois.genet@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH